Reed Elsevier (LON: REL)‘s stock had its “neutral” rating restated by equities researchers at Goldman Sachs in a report issued on Friday. They currently have a $10.51 (700 GBX) target price on the stock, up from their previous target price of $10.51 (700 GBX).

Reed Elsevier traded up 1.69% on Friday, hitting GBX 721.00. Reed Elsevier has a 1-year low of GBX 466.10 and a 1-year high of GBX 725.00. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.682 billion.

A number of other firms have also recently commented on REL. Analysts at Deutsche Bank raised their price target on shares of Reed Elsevier from $11.11 to $11.86 in a research note to investors on Friday. They now have a “buy” rating on the stock. Separately, analysts at Barclays Capital reiterated an “overweight” rating on shares of Reed Elsevier in a research note to investors on Friday. They now have a $12.28 price target on the stock, up previously from $12.16. Finally, analysts at Societe Generale reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Friday. They now have a $12.51 price target on the stock.

Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.